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important cellular components caused by reactive oxygen 
species (ROS) such as free radicals and peroxides. [ 2 ] GSH 
participates in many physiological processes including xeno-
biotic metabolism, intracellular signal transduction, and gene 
regulation. Moreover, GSH also involves in regulating cancer 
cell death, including apoptosis, necrosis, and autophagy. [ 3 ] 
Increased levels of GSH and the resulting resistance to 
chemotherapeutic agents (e.g., doxorubicin and platinum 
containing compounds) in cancer cells have been observed. [ 4 ] 
Due to the importance of GSH, it is desired to develop a 
highly selective and quantitative method to detect GSH. 
 A number of analytical methods based on fl uorescence 
were developed due to its superb selectivity and high sensi-
tivity. The fl uorescence instrumentation is also very simple 
and the detection method is nondestructive to the sample 
under study. Yang and co-workers designed a ratiometric, 
monochlorinated BODIPY-based fl uorescence sensor to 
detect GSH and it can be used in living cells. [ 5 ] Yoon et al. 
successfully prepared two cyanine-based fl uorescent probes 
to detect GSH in cell culture and live mouse tissue. [ 6 ] In 
addition to organic dyes used in the fl uorescence detection, 
quantum dots have also been used to detect GSH. Sensitive DOI: 10.1002/smll.201401658
 Glutathione (GSH) can signifi cantly and selectively enhance the fl uorescence 
intensity of Au nanoclusters (NCs) prepared by blending HAuCl 4 and histidine in 
solution. The quantum yield of the Au NCs after adding GSH can reach above 10%. 
Besides, GSH capping shifts the excitation peak of Au NCs from ultraviolet (386 nm) 
to visible light (414 nm) and improves the stability of the Au NCs. The cytotoxicities of 
the Au NCs with and without GSH for normal lung cells (ATII) and cancerous lung 
cells (A549) are evaluated. The GSH-capped Au NCs have much less cytotoxicity 
to both normal and cancer cells, as compared to those without GSH. For Au NCs 
without GSH, less cytotoxicity is observed in cancer cells than in normal cells. In 
addtion, the Au NCs can selectively detect GSH over cysteine and homocysteine, the 
two biothiols which commonly exist in cells that can seriously affect GSH detection. 
Most importantly, Au NCs without GSH can selectively image the cancer cells, 
especially for the liver cancer cells whose GSH content is much higher than other cell 
types. This property makes the Au NCs a powerful probe to distinguish cancer cells 
from normal cells. 
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 1.  Introduction 
 Glutathione (GSH) is an important antioxidant and the 
most abundant low-molecular thiol in vivo with a concentra-
tion range from 1 to 15 mM. [ 1 ] GSH can prevent damage to 
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turn-on fl uorescence sensors to detect GSH in cells based on 
the recovered fl uorescence of “Au NC−Hg II ” [ 7 ] and “CdTe/
CdSe quantum dot−Hg II ” [ 8 ] have been developed. 
 On the other hand, gold nanoclusters (Au NCs) com-
posed of several to a hundred gold atoms with a typical size 
of 1−5 nm are an important class of fl uorescent nanostruc-
tures that can also be used to detect GSH in vitro and in 
vivo. Like other gold-based nanomaterials that have various 
applications owning to their excellent biocompatibility, [ 9 ] Au 
NCs bearing unique physicochemical properties [ 10 ] are also 
safe and can be used for molecular identifi cation [ 7,11 ] and ion 
detection, [ 12 ] catalysis, [ 13 ] and potential applications in bio-
labeling and sensing. [ 14 ] Au NCs can be synthesized by using 
different capping molecules, such as peptides, [ 15 ] proteins, [ 16 ] 
DNA, [ 17 ] polymers [ 18 ] including PAMAM, [ 19 ] adenine and 
its derivatives, [ 20 ] histidine, [ 21 ] GSH, [ 12c , 15c , 22 ] purine, [ 23 ] dihy-
drolipoic acid, [ 12b ] diphospine, [ 24 ] and alkanethiol. [ 25 ] Among 
these capping reagents, GSH is considered to be excellent 
due to its superb biocompatibility and stability. [ 12c , 15c , 22 ] 
 Herein, we report for the fi rst time that by adding GSH, 
the fl uorescence intensity of Au NCs prepared by blending 
HAuCl 4 and histidine can be signifi cantly, selectively, and lin-
early enhanced. The preparation and characterization of the 
Au NCs made from HAuCl 4 and histidine has already been 
reported by Chen et al. [ 21a ] We found that the thus-prepared 
Au NCs shows a superb ability to selectively detect GSH 
over cysteine (Cys) and homocysteine (Hcy), the two bio-
thiols commonly exist in cells that can seriously affect GSH 
detection. It was also found that the Au NCs without GSH 
can selectively distinguish cancer cells (e.g., lung A549 and 
liver Hep G2 cancer cells) from normal cells (e.g., lung ATII 
and liver L02 cells), based on the different GSH concentra-
tions of the two types of cells. Au NCs were shown to be able 
to cause a much stronger fl uorescence enhancement in liver 
cancer cells (Hep G2 cells) than in lung cancer cells (A549 
cells). Besides, cytotoxicity evaluations of the Au NCs with 
and without GSH were also carried out for normal lung cells 
(ATII) and cancerous lung cells (A549). 
 2.  Results and Discussion 
 The TEM image of the Au NCs revealed no apparent differ-
ence in morphology between the Au NCs containing GSH and 
those without GSH (see supporting information Figure S1). 
However, the GSH-containing Au NCs can be stable for more 
than two weeks, which is much longer than the Au NCs without 
GSH (which will precipitate after storage for 1 or 2 days). We 
collected the UV-Vis absorption spectrum from the Au NCs 
with GSH (e.g., at a GSH:Au ratio of 12:1) between 300 nm 
and 700 nm ( Figure  1 A). There was no absorption detected 
for the wavelength region > 600 nm. Absorption was observed 
between 300 nm and 600 nm, with a small peak centered near 
414 nm. The fl uorescent spectra also indicated that the max-
imum excitation peak centered at 414 nm, a signifi cant shift 
from that of the Au NCs without GSH (384 nm). [ 21a ] Under 
the 414 nm excitation, the sample generated a fl uorescence 
emission peak at about 496 nm (Figure  1 A). Using quinine 
sulfate as the reference, the quantum yield is estimated to be 
about 10% for GSH: Au NCs = 24:1. Further increasing 
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 Figure 1.  (A) UV-Vis absorption spectrum (left) and emission spectrum excited at 414 nm (right) of GSH : Au NCs = 12 : 1 (mol/mol); (B) Photographs 
of GSH mixing with Au NCs using different molar ratios: 0 : 1, 1 : 1, 1.5 : 1, 3 : 1, 6 : 1, 12 : 1, and 24 : 1 (from left to right) under 365 nm 
UV excitations; (C) Fluorescence responses of 50 µM Au NCs after adding GSH to reach different concentrations (0−1200 μM); (D) Plot of the 
relationship between Δ I / I 0 and [GSH] (0−1600 μM).
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the content of GSH can increase the quantum yield of Au 
NCs to above 10%.  Scheme  1 illustrates the general process 
of the GSH-induced fl uorescence enhancement of Au NCs. 
 The fl uorescence intensity of Au NCs increased after 
adding different concentrations of GSH under the 365 nm 
UV irradiation (Figure  1 B). The fl uorescence enhancement of 
Au NCs by different concentrations of GSH was also shown 
in the fl uorescence spectra (Figure  1 C). As the concentration 
of GSH increased, the fl uorescence intensity of Au NCs was 
monotonically enhanced. Figure  1 D showed the change of 
fl uorescence intensity (Δ I / I 0 ) at 496 nm as a function of GSH 
concentration ([GSH]). The Δ I / I 0 values were measured over 
the GSH concentration range of 50−1600 μM. The depend-
ence of Δ I / I 0 on GSH concentration follows two equa-
tions in two concentration ranges: Δ I / I 0 = −3.66 + 0.0732 × 
[GSH] ( R 2 = 0.9945) from GSH concentration of 50 μM to 
150 μM and Δ I / I 0 = 2.17 + 0.0301 × [GSH] ( R 2 = 0.9982) from 
GSH concentration of 150 to 1200 μM, with a detection limit 
of 0.2 μM (at a signal to noise ratio of 3), respectively. As a 
result of the strong Au−S bond, the added GSH (a thiol-con-
taining short peptide) can gradually have a ligand exchange 
with the previous histidine molecules on the surface of Au 
NCs, leading to a signifi cant fl uorescence enhancement of the 
Au NCs. We can also fi t the data (from 50 to 1200 μM) using 
one equation Δ I / I 0 = 0.323 + 0.0322 × [GSH] ( R 2 = 0.9905). 
However, such a simple one-equation fi tting cannot accu-
rately refl ect the [GSH]-dependent fl uorescent intensity 
changes, especially at low GSH concentrations. The different 
fl uorescence responses in two concentrations ranges may 
indicate that there are two stages of GSH interactions with 
Au NCs. We believe that the fl uorescent signal increase after 
the addition of GSH is due to the ligand exchange between 
GSH and histidine. At high GSH concentrations, the increase 
of GSH in the solution may not as effectively replace the 
original histidine ligands on the surface of the Au NCs as in 
the low [GSH] situation, because the Au NC surface already 
has substantial GSH coverage. We also fi nd that the fl uores-
cence intensity changes of a higher GSH:Au ratio of 28:1 
([GSH] = 1400 μM) and 32:1 ([GSH] = 1600 μM) deviate 
from the linear relationship (Figure  1 D). 
 The ligand exchange between histidine and GSH on the 
surface of Au NCs can be verifi ed by XPS. The XPS spectrum 
of the GSH-capped Au NCs shows the binding energies of all 
the elements in the product (Figure S2). Specifi cally, the ele-
ments of C, N, O, and S were detected from Au NCs with his-
tidine and GSH. The presence of the S 2p peak at 162.3 eV 
indicates the interaction of Au NCs with GSH through the 
Au–S bond. The binding energy of Au 4f7/2 shifts from 83.9 eV 
to 82.8 eV after the addition of GSH ( Figure  2 A), indicating 
a reduction of partial Au(I) atoms to Au(0) atoms in Au NCs 
by GSH molecules. The XPS data indicate the strong interac-
tion between GSH and Au NCs. 
 The fl uorescence lifetimes of the Au NCs before and after 
addition of GSH were also measured to study the effect of 
GSH on the fl uorescence properties (Figure  2 B). The decay 
curve of Au NCs without GSH can be fi tted with a double 
exponential function, giving two distinct decay times of 1.58 
and 5.56 ns, respectively. This may imply that there are two 
small 2014, 10, No. 24, 5170–5177
 Scheme 1.  Schematics illustrating the GSH-induced fl uorescence enhancement of Au NCs prepared by mixing HAuCl 4 and histidine.
 Figure 2.  (A) XPS spectra of Au 4f for Au NC (black line) and GSH-capped 
Au NCs (grey line); (B) Time-resolved fl uorescence decay curves of Au 
NCs and GSH-capped Au NCs. 
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competing fast and slow electron transfer processes. After 
adding GSH, the decay curve of Au NCs can be fi tted with 
a single exponential function, giving a decay time of 8.29 ns. 
The longer lifetime of Au NCs after the addition of GSH 
implied that GSH (which was bound to the surface of Au 
NCs) acted as an electron donor to enhance the fl uorescence 
of Au NCs. [ 26 ] 
 Since the Au NCs will be used for detecting GSH, we also 
studied the possible fl uorescence enhancement effect of Au 
NCs caused by other common molecules in the cell medium. 
As shown in  Figure  3 , the fl uorescence intensity of the Au 
NCs exhibited a signifi cant enhancement by adding GSH to 
the solution, whereas other molecules such as amino acids 
including L-glutamic acid (Glu), glycine (Gly), D,L-homo-
cysteine (Hcy), L-serine (Ser), L-arginine (Arg), L-lysine 
(Lys), L-cysteine (Cys), and L-glutamine (Gln), small mol-
ecules (including DTT and glucose) and ions (including K + , 
Na + , and Ca 2+ ) did not cause similar obvious fl uorescence 
changes compared to GSH. Figure  3 shows that the Au NCs 
can sensitively distinguish GSH from Hcy and Cys. Hcy and 
Cys are also thiol-containing molecules and involved in many 
physiological processes, especially in the cellular antioxidant 
defense system. Hcy is an important marker for cardiovas-
cular disease [ 27 ] and osteoporotic fracture. [ 28 ] While as a 
precursor to GSH, Cys is an important source of sulfi de in 
human metabolism and plays an important role in infl uencing 
protein structure. [ 29 ] Therefore Hcy and Cys are widely avail-
able in the cell medium. Here we clearly demonstrated that 
Hcy and Cys will not interfere with the detection of high con-
centration of GSH using Au NCs. 
 Two possible reasons may explain why other thiol-con-
taining molecules (such as DTT, Hcy, and Cys) cannot sig-
nifi cantly enhance the fl uorescence intensity of Au NCs like 
GSH. The fl uorescence enhancement may be attributed to 
the so-called “charge transfer from the ligands to the metal 
center (LMNCT)” mechanism through the Au–S bonds. The 
LMNCT mechanism has been widely used to explain the 
luminescence and luminescent enhancement of noble metal 
nanoclusters protected by thiol ligands, such as alkanethiol 
and glutathione. [ 30 ] In the case of Au NCs, the formation of 
the Au–S bond after the addition of thiol compound implied 
that the charge transfer might occur between the Au NCs 
and the thiol compound. Compared with Hcy and Cys, GSH 
contains more electron-rich groups, such as carboxyl group 
(COOH) and amino group (NH 2 ), which might also con-
tribute to the fl uorescence enhancement. [ 31 ] Another possible 
explanation is the large steric hindrance effect created by 
GSH (larger than DTT, Hcy, and Cys), which enhances the 
coordination stability to metal atoms. [ 7,8 ] The stable structure 
may also lead to the signifi cant fl uorescence enhancement. 
 We have tested the fl uorescence intensity of the Au NCs 
when GSH, Hcy, and Cys are coexisted. Compared to the fl uo-
rescence intensity generated from Au NCs blending only with 
GSH (Au:GSH = 1:12, mol/mol), the fl uorescence intensity of 
Au NCs mixing with GSH, Hcy, and Cys (Au:GSH:Hcy:Cys = 
1:12:12:12, mol/mol/mol/mol) decreased by ∼40% after incu-
bation for 12 h. This demonstrates that the two other thiol-
containing molecules (Hcy and Cys) may compete with GSH 
to interact with Au NCs. As we observed and explained 
above, the enhancement effect of GSH is larger than Hcy and 
Cys, therefore when GSH, Hcy and Cys are coexisted, the Au 
NC fl orescence intensity is weaker than the case when GSH 
is present alone. In certain cells and tissues, the content of 
GSH is higher than those of Hcy and Cys, and thus the com-
peting effect of Hcy and Cys will not signifi cantly affect the 
GSH-induced fl uorescence enhancement. 
 We have also tested if GSH can enhance the fl uorescence 
intensity of Au NCs prepared using other methods, e.g., by 
mixing HAuCl 4 and BSA. 
[ 16a ] The results shown in the Figure 
S3 indicated that the fl uorescence intensity of Au NCs could 
also be signifi cantly enhanced by the presence of GSH, which 
suggested that the GSH-caused fl uorescence enhancement 
should be a general phenomenon for Au NCs. 
 In comparison to other fl uorescence probes, the Au NCs 
probe has three advantages. First of all, the system is “clean” 
and there are no other heavy metals (besides gold) in the 
system. Previous studies detected GSH using fl uorescence 
quenching of Au NCs with heavy metal ions (such as mercury 
ion) and recovery of the fl uorescence as a result of the pref-
erable affi nity of GSH with heavy metal ions. [ 7,8 ] Most heavy 
metals are toxic and their accumulation over time in the body 
can cause serious illness. Thus, here we developed a much 
safer method to detect GSH in living cells. Secondly, the cur-
rent probe is easy to prepare, simply by blending HAuCl 4 
and histidine in solution at room temperature. No organic 
synthesis, redox reaction, separation or purifi cation steps are 
needed in the entire experimental procedures. Moreover, 
the system has a specifi c sensitivity and high selectivity to 
detect GSH. The interference of other possible coexisting 
substances in cell medium is low, especially for those bio-
thiols with similar structures and reactivities (e.g., Hcy and 
Cys). Previously because both of the two thiol-containing 
molecules Hcy and Cys strongly interfered with GSH detec-
tion, [ 32 ] the GSH detection has signifi cant challenges. [ 33 ] 
 MTT assay experiments showed that the Au NCs (without 
GSH) are more toxic to normal ATII cells ( Figure  4 A) than 
cancerous A549 cells (Figure  4 B). For example, after the 
addition of 300 μM Au NCs to both types of the cells, the 
measured cell viabilities for A549 and ATII cells are ∼82% 
and ∼33%, respectively. After adding the GSH-capped 
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 Figure 3.  Fluorescence responses of 50 μM Au NCs with different guest 
molecules. The concentrations of all guests are 600 μM.
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Au NCs, the cytotoxicity of Au NCs to ATII (Figure  4 C) 
and A549 (Figure  4 D) cells signifi cantly decreased. It was 
observed that at the highest concentration of 1000 μM GSH-
capped Au NCs, the cell viability values of ATII and A549 
cells are still measured to be ∼75% and ∼76%, respectively. 
In contrast, after adding 1000 μM Au NCs (without GSH), 
the cell viability values of ATII and A549 cells are only ∼3% 
and ∼4%, respectively. This indicates that the incorporation 
of GSH to Au NCs can signifi cantly protect both normal cells 
and cancer cells. This can in turn explain the result that the 
cancerous A549 cells are more resistant to Au NCs compared 
with normal ATII cells, since the cancer cells have a higher 
content of GSH relative to normal cells. As an effective 
antioxidant, GSH can prevent damage of important cellular 
components caused by reactive oxygen species (ROS), which 
shows that the predominant reason for the cytotoxicity of Au 
NCs at concentrations higher than 100 μM is the production 
of ROS within cells after exposure to Au NCs. However, the 
above MTT assay results show that the two kinds of Au NCs 
(with or without GSH) are not toxic to either normal cells 
or cancer cells at concentrations of 100 μM or below, which 
makes the Au NCs suitable for other applications such as cell 
imaging. 
 To demonstrate if the Au NCs have the ability to selec-
tively image cancer cells, we chose two kinds of human cell 
lines, the liver cells (including normal L02 cells and can-
cerous Hep G2 cells) and lung cells (including normal ATII 
cells and cancerous A549 cells), and used confocal micros-
copy to study the imaging effects of the Au NCs prepared by 
HAuCl 4 and histidine. ATII cells have a very weak autofl uo-
rescence intensity, and the results in  Figure  5 A and C show 
that the addition of 100 μM Au NCs to ATII cells did not 
cause noticable change in the fl uorescence intensity of the 
cells. For A549 cells, the addition of 100 μM Au NCs resulted 
in the formation of some bright fl uorescence dots within the 
cells (Figure  5 D and Figure S4), whose fl uorescence intensity 
is much higher as compared to the autofl uorescence inten-
sity of the A549 cells (Figure  5 B). Such a fl uorescence dot 
small 2014, 10, No. 24, 5170–5177
 Figure 4.  Cytotoxicity results of Au NCs and GSH-capped Au NCs (with the GSH/Au molar ratio of 12 : 1) on ATII (A and B) and A549 cells (C and 
D) determined by MTT assay.
 Figure 5.  Confocal fl uorescence images of (A) ATII cells without Au NCs, 
(B) A549 cells without Au NCs, (C) ATII cells with 100 µM Au NCs and 
(D) A549 cells with 100 µM Au NCs. Cell images were obtained using 
an excitation wavelength of 405 nm. The fl uorescence intensity in the 
area along the line marked in (D) will be quantifi ed in Figure  7 A below.
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formation character is more pronounced in cancerous liver 
cell lines after the addition of Au NCs ( Figure  6 ). After 
adding 100 μM Au NCs to L02 cells, there was no apparent 
fl uorescence intensity change before (Figure  6 A) and after 
the addition of Au NCs (Figure  6 C). While for Hep G2 cells, 
intense green fl uorescence dots appeared within the cyto-
plasm of the cells after the addition of Au NCs (Figure  6 D). 
The fl uorescence enhancement in the two cancerous cells 
may be related to the elevated GSH concentrations in cancer 
cells as compared to the corresponding normal cells. Besides, 
it has been reported that the content of GSH in liver is about 
4−7 times higher than that in lung, heart, and brain, [ 34 ] which 
may account for the observed more evident fl uorescent dot 
formation in cancerous liver cells. Our present work shows 
that the Au NCs prepared from HAuCl 4 and histidine can be 
used as an excellent sensor for GSH within living cells, and 
can selectively image cancer cells, especially for liver cancer 
cells. 
 To quantify the occurrence frequency of the fl uores-
cent dots within A549 and Hep G2 cells after the addi-
tion of Au NCs, we measured the fl uorescence intensities 
in the areas along the straight lines marked in the confocal 
images in Figure  5 D and Figure  6 D and showed the results 
in  Figure  7 A,B. Under the same 405 nm excitation, the fl uo-
rescence intensities of the two samples are similar. However, 
the occurrence frequency of the fl uorescent dots in the “Hep 
G2 + Au NCs” sample is much higher than that in the “A549 + 
Au NCs” sample. Besides, the fl uorescence intensities of Au 
NCs in each cell were obtained by calculating the integrated 
intensity of the cell divided by the cell area (Figure  7 C). The 
results also showed that the integrated fl uorescence intensity 
in Hep G2 cells after the addition of Au NCs was larger than 
that in A549 cells. 
 GSH reduces disulfi de bonds within cytoplasmic pro-
teins to thiols while being oxidized to GSSG and can be 
regenerated from GSSG by the enzyme glutathione reduc-
tase. In healthy cells and tissues, more than 90% of the 
total glutathione exists in the reduced form (GSH) and an 
increased GSSG-to-GSH ratio is considered to be indicative 
of oxidative stress. [ 35 ] The ROS stress in cancer cells is much 
greater than that in normal cells. As a result, more reduced 
glutathione (GSH) than oxidized glutathione (GSSG) is 
produced, which can have ligand exchange with the Au NCs, 
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 Figure 6.  Confocal images of (A) L02 cells without Au NCs, (B) Hep G2 
cells without Au NCs, (C) L02 cells with 100 µM Au NCs and (D) Hep G2 
cells with 100 µM Au NCs. Cell images were obtained using an excitation 
wavelength of 405 nm. The fl uorescence intensity in the area along the 
line marked in (D) will be quantifi ed in Figure  7 B below.
 Figure 7.  Fluorescence intensities of the red lines marked in the 
confocal images for (A) A549 + Au NCs (Figure  5 D) and (B) Hep G2 + 
Au NCs (Figure  6 D). (C) Integrated fl uorescence intensity of A549 
(Figure S4) and Hep G2 (Figure  6 D) cells after incubation with Au NCs 
for 24 h.
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producing enhanced fl uorescent signals within the cancer 
cells. Our present work demonstrates that the Au NCs can 
effectively distinguish the cancer cells and normal cells by 
taking advantage of the GSH-enhanced mechanism of the Au 
NCs. 
 3.  Conclusion 
 We have discovered that GSH can cause the fl uorescence 
enhancement of Au NCs prepared by blending HAuCl 4 and 
histidine and protect both normal cells and cancer cells by 
reducing the cytotoxicity of the Au NCs. The quantum yield 
of the Au NCs after adding GSH can reach above 10%. Au 
NCs without GSH are more toxic to normal cells as com-
pared to cancer cells due to the higher GSH concentration in 
cancer cells. The Au NCs without GSH can selectively image 
cancer cells, especially for liver cancer cells. Besides, the 
Au NCs prepared can effi ciently detect GSH over cysteine 
(Cys), homocysteine (Hcy), and other common cell medium 
components. 
 4.  Experimental Section 
 Materials : HAuCl 4 ·3H 2 O, L-histidine (His), L-glutathione (GSH), 
L-glutamic acid (Glu), L-arginine (Arg), L-lysine (Lys), L-serine (Ser), 
L-glutamine (Gln), L-cysteine (Cys), glycine (Gly), D,L-homocysteine 
(Hcy), dithiothreitol (DTT), glucose, KCl, NaCl, CaCl 2 , and quinine 
sulfate were purchased from Sigma-Aldrich. All solutions were 
prepared with deionized water (18.2 MΩ·cm) purifi ed by a Milli-Q 
system (Millipore). 
 Synthesis of Au NCs : All glassware was cleaned in a bath of 
freshly prepared aqua regia (HCl:HNO 3 , 3:1 v/v) and rinsed thor-
oughly in Milli-Q water prior to use. An aqueous solution of histi-
dine (15 mL, 0.1 M) was added to an aqueous solution of HAuCl 4 
(5 mL, 10 mM) in a small vial at room temperature (about 25 °C). 
The solution mixture was blended gently at the beginning and then 
was placed at room temperature without stirring in dark for more 
than 3 h to prepare Au NC precursor solution. A series of GSH solu-
tions were prepared with the concentrations varying from 0, 1.25, 
2.5, 3.75, 5, 7.5, 15, 22.5, 30, 45, 60, 70, and 80 mM, respec-
tively. An equal volume (1 mL) of the above-prepared GSH solution 
was then mixed with the above Au NC precursor solution to acquire 
a GSH:Au molar ratio of 0, 0.5, 1, 1.5, 2, 3, 6, 9, 12, 18, 24, 28, 
and 32. Afterwards, the mixtures were incubated without stirring 
in dark at room temperature overnight to prepare the fi nal Au NCs. 
 Characterization of Au NCs : UV-Vis absorption spectra 
were recorded with a UV-2600 spectrophotometer (Shimadzu). 
Fluorescence spectra were collected on a RF-5301PC spectro-
fl uorophotometer (Shimadzu) and an F-7000 fl uorescence spec-
trophotometer (Hitachi). Transmission electron microscopic 
experiment (TEM) was performed on a JEM-2100 transmission 
electron microscope (JEOL). X-ray photoelectron spectroscopy 
(XPS) analysis was conducted by a PHI Quantera II X-ray photoelec-
tron spectrometer (Ulvac-Phi). Fluorescence decay time measure-
ment was obtained at 496 nm emission wavelength using 405 nm 
excitation on a FLS920 time-resolved fl uorescence spectrometer 
(Edinburgh Instruments). 
 MTT Assay : To test the cytotoxicity of Au NCs in vitro, ATII 
and A549 cells were cultured in cell medium (DMEM), supple-
mented with 10% fetal bovine serum, 100 U of penicillin, and 
100 mg/mL streptomycin in a humidifi ed incubator at 37 °C and 
5% CO 2 . For the MTT toxicity test of Au NCs, the two cells were 
seeded in a 96-well plate in cell medium overnight and subse-
quently incubated with different concentrations of Au NCs (0, 10, 
30, 100, 300, 600, and 1000 μM) in cell medium for 24 h at 37 °C 
and 5% CO 2 . Afterwards, cell medium in each well was removed 
and each well was washed by PBS buffer. 100 μL cell medium con-
taining 0.5 mg/mL MTT was added to each well. After incubation 
for 4 h at 37 °C and 5% CO 2 , 150 μL DMSO was added to each 
well and mixed. The absorbance at 570 nm was measured with a 
Multiskan FC microplate photometer (Thermo). 
 Cell Imaging : L02 cells (normal liver cells), Hep G2 cells 
(cancerous liver cells), ATII cells (normal lung cells), and A549 
cells (cancerous lung cells) were selected for using in this study. 
The cells were seeded in a Lab-Tek 8-well chambered coverglass 
(Nunc). After culturing for 24 h, 100 µM fresh Au NCs prepared 
by blending HAuCl 4 and histidine together were added to the cell 
medium. After incubation for another 24 h, the cells were washed 
with PBS and quickly observed under a confocal laser-scanning 
microscope (CLSM, Leica TCS-SP8) with an excitation wavelength 
of 405 nm. The confocal fl uorescence images were quantitatively 
analyzed using the Image J software. The fl uorescence intensity of 
Au NCs within each cell was obtained by calculating the integrated 
intensity divided by the cell area. 
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